fda glp-1 news november 2025 The has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing Beyond the Headlines: FDA Warning

Clinically, the results of the injectable and oral formulations are comparable, with the main difference being how the medication enters the bloodstream

Because GLP-1 drugs send signals to the brain telling people to feel full on fewer calories, those taking them are often operating in a caloric deficit

These compounded versions arent reviewed by the FDAin fact, the FDA announced Friday that it had asked the Justice Department, out of concern for consumer safety, to investigate Hims & Hers for selling compounded GLP-1 pills

From athletes like Serena Williams to longestablished figures such as Vanessa Williams and Oprah Winfrey, public figures are increasingly placing GLP1 medications within their weightmanagement stories